Evidence map›Paper›PMID 26896000›Full record

ArticleBMC cancer2016

CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer.

M Mego, D Cholujova, G Minarik, T Sedlackova, P Gronesova, M Karaba, J Benca, S Cingelova, Z Cierna, D Manasova and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Could circulating tumor cells explain why breast conservation improves survival despite higher locoregional recurrence?Translational breast cancer research : a journal focusing on translational research in breast cancer · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

M Mego2nd Department of Oncology, Faculty of Medicine, Comenius University, Klenova 1, 833 10, Bratislava, Slovak Republic. misomego@gmail.com.
D CholujovaNational Cancer Institute, Bratislava, Slovakia. dana.cholujova@savba.sk.
G MinarikInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia. gabriel.minarik@gmail.com.
T SedlackovaInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia. tatiana.sedlackova@gmail.com.
P GronesovaCancer Research Institute, Slovak Academy of Sciences, Slovak Medical University, Bratislava, Slovakia. paulina.gronesova@gmail.com.
M KarabaNational Cancer Institute, Bratislava, Slovakia. marian.karaba@nou.sk.
J BencaNational Cancer Institute, Bratislava, Slovakia. juraj.benca@nou.sk.
S CingelovaNational Cancer Institute, Bratislava, Slovakia. silvia.cingelova77@gmail.com.
Z CiernaDepartment of Pathology, Faculty of Medicine, Comenius University, Bratislava, Slovakia. ciernaz@gmail.com.
D ManasovaTranslational Research Unit, Faculty of Medicine, Comenius University, Bratislava, Slovakia. d.manasova@gmail.com.
D PindakNational Cancer Institute, Bratislava, Slovakia. daniel.pindak@nou.sk.
J Sufliarsky2nd Department of Oncology, Faculty of Medicine, Comenius University, Klenova 1, 833 10, Bratislava, Slovak Republic. jozef.sufliarsky@nou.sk.
M CristofanilliRobert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. Massimo.Cristofanilli@nm.org.
J M ReubenDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center Houston, Houston, TX, USA. jreuben@mdanderson.org.
J Mardiak2nd Department of Oncology, Faculty of Medicine, Comenius University, Klenova 1, 833 10, Bratislava, Slovak Republic. jozef.mardiak@nou.sk.
National Institute of Cardiovascular Diseases · SKComenius University Bratislava · SKNorthwestern University · USSlovak Medical University · SKThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCytokines are involved in cancer invasion and metastasis. Circulating tumor cells (CTCs) play key role in tumor dissemination and are an independent survival predictor in breast cancer patients. The aim of this study was to assess correlation between CTCs and plasma cytokines in primary breast cancer (PBC) patients.

methodsThis study included 147 chemotherapy naïve PBC patients. Peripheral blood mononuclear cells (PBMC) were depleted of hematopoetic cells using RossetteSep™ negative selection kit. RNA extracted from CD45-depleted PBMC was interrogated for expression of EMT (Twist1, Snail1, Slug, Zeb1) and epithelial (Ck19) gene transcripts by qRT-PCR. The concentrations of 51 plasma cytokines were measured using multiplex bead arrays.

resultsCTCs were detected in 25.2% patients. CTCs exhibiting only epithelial markers (CTC_EP) and only EMT markers (CTC_EMT) were present evenly in 11.6% patients, while CTCs co-expressing both markers were detected in 2.0% patients. Patients with presence of CTC_EP in peripheral blood had significantly elevated levels of plasma IFN-α2, IL-3, MCP-3, β-NGF, SCF, SCGF-β, TNF-β and SDF-1 compared to patients without CTC_EP. CTC_EP exhibited overexpression of SDF-1 receptor and CXCR4, but not other corresponding cytokine receptor, and in multivariate analysis SDF-1 was independently associated with CTC_EP. There was an inverse correlation between CTC_EMT and plasma cytokines CTACK, β-NGF and TRAIL, while presence of either subtype of CTCs was associated with increased level of TGF-β2.

conclusionUsing cytokine profiling, we identified cytokines associated with CTCs subpopulations in peripheral blood of PBC. Our data suggest that CXCR4-SDF-1 axis is involved in mobilization and trafficking of epithelial CTCs.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsCell Line, TumorChemokine CXCL12FemaleHCT116 CellsHeLa CellsHumansMCF-7 CellsMiddle AgedNeoplastic Cells, CirculatingReceptors, CXCR4Chemokine CXCL12CXCL12 protein, humanCXCR4 protein, humanReceptors, CXCR4

Identifiers

PMID26896000
PMCPMC4759765
OpenAlexW2284931487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.